These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Biomarkers in cancer micrometastasis: where are we at? Gerges N; Jabado N Bioanalysis; 2010 May; 2(5):881-99. PubMed ID: 21083219 [TBL] [Abstract][Full Text] [Related]
4. MicroRNAs and other small silencing RNAs in cancer. Rovira C; Güida MC; Cayota A IUBMB Life; 2010 Dec; 62(12):859-68. PubMed ID: 21154820 [TBL] [Abstract][Full Text] [Related]
5. Cancer proteomics and its application to discovery of therapy response markers in human cancer. Smith L; Lind MJ; Welham KJ; Cawkwell L; Cancer; 2006 Jul; 107(2):232-41. PubMed ID: 16752413 [TBL] [Abstract][Full Text] [Related]
6. Biological markers in lung cancer: A clinician's perspective. Tufman A; Huber RM Cancer Biomark; 2010; 6(3-4):123-35. PubMed ID: 20660959 [TBL] [Abstract][Full Text] [Related]
7. [Proteomics for biomarker development toward personalized medicine]. Kondo T Rinsho Byori; 2012 Jul; 60(7):644-9. PubMed ID: 22973724 [TBL] [Abstract][Full Text] [Related]
8. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy. Calvo KR; Liotta LA; Petricoin EF Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423 [TBL] [Abstract][Full Text] [Related]
9. [Molecular-target drug]. Sone S; Yano S; Nishioka Y Gan To Kagaku Ryoho; 2004 Jul; 31(7):1034-40. PubMed ID: 15272581 [TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cells: detection, molecular profiling and future prospects. Jacob K; Sollier C; Jabado N Expert Rev Proteomics; 2007 Dec; 4(6):741-56. PubMed ID: 18067413 [TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells. Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644 [TBL] [Abstract][Full Text] [Related]
12. Oncoproteomics: current trends and future perspectives. Cho WC; Cheng CH Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924 [TBL] [Abstract][Full Text] [Related]
13. Challenges for biomarkers in cancer detection. Wagner PD; Verma M; Srivastava S Ann N Y Acad Sci; 2004 Jun; 1022():9-16. PubMed ID: 15251933 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Cho WC Int J Biochem Cell Biol; 2010 Aug; 42(8):1273-81. PubMed ID: 20026422 [TBL] [Abstract][Full Text] [Related]
15. Discovery and development of biomarkers of neurological disease. Dunckley T; Coon KD; Stephan DA Drug Discov Today; 2005 Mar; 10(5):326-34. PubMed ID: 15749281 [TBL] [Abstract][Full Text] [Related]
16. Proteomic approaches in lung cancer biomarker development. Cho JY; Sung HJ Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125 [TBL] [Abstract][Full Text] [Related]
17. Genomics and proteomics of bone cancer. Marguiles AG; Klimberg VS; Bhattacharrya S; Gaddy D; Suva LJ Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6217s-6221s. PubMed ID: 17062704 [TBL] [Abstract][Full Text] [Related]
18. Cancer biomarkers: current issues and future directions. Jain KK Curr Opin Mol Ther; 2007 Dec; 9(6):563-71. PubMed ID: 18041667 [TBL] [Abstract][Full Text] [Related]
19. Cancer: a proteomic disease. Li G; Xiao Z; Liu J; Li C; Li F; Chen Z Sci China Life Sci; 2011 May; 54(5):403-8. PubMed ID: 21455689 [TBL] [Abstract][Full Text] [Related]
20. Proteomics in investigation of cancer metastasis: functional and clinical consequences and methodological challenges. Maryáš J; Faktor J; Dvořáková M; Struhárová I; Grell P; Bouchal P Proteomics; 2014 Mar; 14(4-5):426-40. PubMed ID: 24272997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]